Company: CYTK
Filing Date: 2025-09-22
Form Type: 8-K
Source: 0001193125-25-209437
Chunk: 1

Company: CYTOKINETICS INC
Filing Date: 2025-09-22
Form: 8-K
Item: Item 1.01
Chunk 1
---
 stock, $0.001 par value per share (the “common stock”), exceeds 130% of the conversion price for each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (ii) during the five consecutive business days immediately after any 10 consecutive trading day period (such 10 consecutive trading day period, the “measurement period”) if the trading price per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of the Company’s common stock on such trading day and the conversion rate on such trading day; (iii) upon the occurrence of certain corporate events or distributions on the Company’s common stock, as described in the Indenture; (iv) if the Company calls such Notes for redemption; and (v) at any time from, and including, July 1, 2031 until the close of business on the second scheduled trading day immediately before the maturity date.

The initial conversion rate is 14.6156 shares of common stock per $1,000 principal amount of Notes, which represents an initial conversion price of approximately $68.42 per share of common stock. The conversion rate and conversion price will be subject to customary adjustments upon the occurrence of certain events as described in the Indenture. In addition, if certain corporate events that constitute a “ Make-Whole Fundamental Change” (as defined in the Indenture) occur, then the conversion rate will, in certain circumstances, be increased for a specified period of time.

The Company may not redeem the Notes at its option at any time before October 6, 2028. The Notes will be redeemable, in whole or in part (subject to the “ Partial Redemption Limitation” (as defined in the Indenture)), at the Company’s option at any time, and from time to time, on a redemption date on or after October 6, 2028 and, in the case of any partial redemption, on or before the 40th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date, but only if (i) the Notes are “ Freely Tradeable” (as defined in the Indenture) as of the